Inside The COVID-19 Pipeline
An Interactive View Of Vaccines & Treatments In Development
Updated daily as additional research gets underway, this pipeline tracker follows the global effort to find drugs that could help treat COVID-19 and the symptoms it causes, and accelerate a vaccine that could help limit the spread of the pandemic.
You may also be interested in...
Private Company Edition: The average exit from biopharma investments rose from $356.8m in 2019 to $520.6m in 2020, explaining the staggering $12bn invested in the industry during the first half of this year versus $17bn for all of last year. In recent VC deals, VelosBio’s $137m series B was the largest.
Plus: Sinovac promises to develop its vaccine for global use.
The FDA has almost 30 decision dates coming up before New Year’s Eve, including nearly a dozen novel agents.